narcolepsy type 1, narcolepsy type 2, idiopathic hypersomnia sleep disorders with excessive daytime sleepiness
Conditions
Interventions
Online questionnaire
Sponsors
SEIN - Stichting epilepsie instellingen nederland
Eligibility
Age
16 Years to 99 Years
Inclusion criteria
Inclusion criteria: At least 16 years old, legally competent.For the NT1 group: a (primary) diagnosis of narcolepsy type 1 according to the ICSD-3 TR criteria.For the control group with other central hypersomnolence: a diagnosis of narcolepsy type 2 or idiopathic hypersomnia according to the ICSD-3 TR criteria.For the control group with another type of sleep–wake disorder: a diagnosis of insomnia or sleep apnea according to the ICSD-3 TR criteria.Currently or previously treated at the SEIN sleep–wake center between January 2015 and December 2025.Has given permission to SEIN to be contacted for scientific research.Available email address.
Exclusion criteria
Exclusion criteria: N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Is an (additional) immune disease more common in people with NT1 than in people with another type of sleep disorder (insomnia/sleep apnea)? | — |
Secondary
| Measure | Time frame |
|---|---|
| Is an (additional) immune disease more common in the biological parents of people with NT1 than in those of people with another type of sleep disorder (insomnia/sleep apnea)?Is an (additional) immune disease more common in people with NT1 (or their biological parents) than in people with another central hypersomnolence disorder (NT2/IH)?Is an (additional) immune disease more common in people with NT1 (or their biological parents) than would be expected based on data from the general population? | — |
Countries
Netherlands
Contacts
Public ContactGJ Lammers
SEIN - stichting epilepsie instellingen nederland
Outcome results
None listed